DCM
DRUG

Driehaus Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Driehaus Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.6M Buy
432,515
+162,874
+60% +$13.1M 0.23% 141
2025
Q4 		$21M Buy
+269,641
New +$18M 0.14% 200

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Driehaus Capital Management's DRUG Position: Q1 2026 in Review

Driehaus Capital Management increased its Bright Minds Biosciences (DRUG) stake by 60% in Q1 2026, buying an estimated $13.1M and bringing the position to 432,515 shares worth $31.6M. The position accounts for 0.23% of the portfolio, ranked #141.

Driehaus Capital Management first reported a position in DRUG in Q4 2025 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Driehaus Capital Management held 432,515 shares of Bright Minds Biosciences worth $31.6M as of Q1 2026.
  • Driehaus Capital Management bought 162,874 Bright Minds Biosciences shares in Q1 2026, an estimated $13.1M.
  • Bright Minds Biosciences made up 0.23% of Driehaus Capital Management's portfolio in Q1 2026, its #141 holding.
  • Driehaus Capital Management first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.